Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2023 | 2 |
2024 | 1 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Targeting Sphingosine-1-Phosphate Signaling in Breast Cancer.
Int J Mol Sci. 2024 Mar 15;25(6):3354. doi: 10.3390/ijms25063354.
Int J Mol Sci. 2024.
PMID: 38542328
Free PMC article.
Review.
Baseline interleukin-6 is a prognostic factor for patients with metastatic breast cancer treated with eribulin.
Bun A, Nagahashi M, Kuroiwa M, Komatsu M, Miyoshi Y.
Bun A, et al.
Breast Cancer Res Treat. 2023 Dec;202(3):575-583. doi: 10.1007/s10549-023-07086-9. Epub 2023 Sep 21.
Breast Cancer Res Treat. 2023.
PMID: 37733188
Free PMC article.
Item in Clipboard
Copy number alteration is an independent prognostic biomarker in triple-negative breast cancer patients.
Nagahashi M, Ling Y, Toshikawa C, Hayashida T, Kitagawa Y, Futamura M, Kuwayama T, Nakamura S, Yamauchi H, Yamauchi T, Kaneko K, Kanbayashi C, Sato N, Tsuchida J, Moro K, Nakajima M, Shimada Y, Ichikawa H, Lyle S, Miyoshi Y, Takabe K, Okuda S, Wakai T.
Nagahashi M, et al.
Breast Cancer. 2023 Jul;30(4):584-595. doi: 10.1007/s12282-023-01449-2. Epub 2023 Mar 17.
Breast Cancer. 2023.
PMID: 36930419
Item in Clipboard
Cite
Cite